FDA advisors backed the Wolverine stack. The supply chain is gearing up for what comes next.

August 5, 2026  |  10:00 AM – 1:00 PM ET

Last week, an FDA advisory committee backed loosened restrictions on six wellness peptides — including the "Wolverine stack" — setting aside the FDA's own scientists' objections. Compounding pharmacies are ready to move. But the path to legal, quality access is still complicated.

Tomorrow, we dig in. The peptide market is at an inflection point. Join us to hear what comes next.

SPONSORED BY